Grannum R. Sant, MB, BCh, BAO (Hons.), MA, MD, FRCS, FACS
Department of Urology, Tufts University School of Medicine, Boston, MA, USA
Research interest: Prostate Cancer; Female Urology; Biomarkers
Dr.Grannum Sant serves as Professor and Chair of Urology, Tufts University School of Medicine (Distinguished Faculty Award) and Urologist-in-Chief, Tufts Medical Center Hospitals in USA. He also hold academic committee leadership positions with the National Institutes of Health (NIH-NIDDK), American Urological Association (AUA), Past-President New England Section AUA, and American Board of Urology (ABU) Examination Committee.
He has published over 128 peer-reviewed publications, 36 book chapters, 2 textbooks (Pathophysiologic Principles of Urology; Interstitial Cystitis), and 10 Urology Journal Supplement Editorships. He has been responsible for the medical affairs launch of Uroxatral for BPH and Eligard for prostate cancer.
He has successfully recruited, built, and led 5 medical affairs teams including 3 US (Urology, Oncology at Sanofi and Rare Diseases at Genzyme) and 2 Global (Rare Genetic Diseases and Cardiovascular (Familial Hypercholesterolemia) at Genzyme including 3 US Medical Science Liaison (MSL) teams (Urology, Rare Genetic Diseases and Familial Hypercholesterolemia).
Associate Editor
Terms of Appointment: September 2014 - August 2016; September 2016 - August 2018; September 2018 - November 2020; December 2020 - November 2022; December 2022 - November 2024